Sinopharm
1099.HK
#2721
Rank
โ‚น635.89 B
Marketcap
โ‚น203.77
Share price
-1.76%
Change (1 day)
-3.55%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.842 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.842 Trillion. In 2025 the company made a revenue of โ‚น7.842 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.640 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.842 T2.65%
2024โ‚น7.640 T-5.1%
2023โ‚น8.051 T5.42%
2022โ‚น7.637 T-2.1%
2021โ‚น7.800 T16.85%
2020โ‚น6.675 T14.95%
2019โ‚น5.807 T21.52%
2018โ‚น4.778 T5.93%
2017โ‚น4.511 T27.22%
2016โ‚น3.546 T5.37%
2015โ‚น3.365 T9.14%
2014โ‚น3.083 T17.22%
2013โ‚น2.630 T25.94%
2012โ‚น2.088 T34.61%
2011โ‚น1.551 T55.34%
2010โ‚น998.81 B35.79%
2009โ‚น735.56 B37.56%
2008โ‚น534.73 B31.43%
2007โ‚น406.87 B40.26%
2006โ‚น290.07 B